Long-term safety of azathioprine for treatment of neuromyelitis optica spectrum disorders
ABSTRACT Background: Azathioprine is a common first-line therapy for neuromyelitis optica spectrum disorder (NMOSD). Objective: The aim of this study was to determine whether long-term treatment (>10 years) with azathioprine is safe in NMOSD. Methods: We conducted a retrospective medical record...
Gardado en:
| Principais autores: | , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Thieme Revinter Publicações
2021-03-01
|
| Series: | Arquivos de Neuro-Psiquiatria |
| Assuntos: | |
| Acceso en liña: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2021000300229&tlng=en |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|